Laurus Labs, based in Hyderabad (India), is a leading developer and manufacturer of generic active pharmaceutical ingredients (“API”), with a focus on products where it has cost leadership led by innovation in process chemistry or manufacturing efficiencies. Since the start of commercial operations in 2008, Laurus Labs has built a leadership position in antiretroviral (“ARV”) APIs. Over time, it has expanded its portfolio to include oncology and other select APIs where it has a cost advantage. In its largest business segment of ARV API, Laurus Labs has emerged as a leading independent supplier to formulation companies catering to the large and fast-growing markets of low- and middle-income countries (e.g., Africa and Latin America). Laurus Labs was founded in 2005 by Dr. C. Satyanarayana, who is currently the CEO and has over 26 years of experience in the pharmaceutical industry across R&D, manufacturing and business development.